Hi there... I understand your concern... rituximab, an anti-CD20 chimeric monoclonal antibody, has shown promising results in patients with refractory ITP....side effects include fever, chills, and body aches, which usually occur with the first infusion and are successfully managed with available drugs...discuss the issue with your treating doctors they will guide you further.
Answered2016-05-28 02:29:24
Let others know if this answer was helpful